Thomas Wagels

564 total citations
9 papers, 417 citations indexed

About

Thomas Wagels is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Thomas Wagels has authored 9 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 4 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Thomas Wagels's work include HIV/AIDS drug development and treatment (8 papers), HIV/AIDS Research and Interventions (6 papers) and HIV Research and Treatment (4 papers). Thomas Wagels is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV/AIDS Research and Interventions (6 papers) and HIV Research and Treatment (4 papers). Thomas Wagels collaborates with scholars based in Switzerland, Chile and Canada. Thomas Wagels's co-authors include Bruno Ledergerber, Milos Opravil, Martin Rickenbach, Enos Bernasconi, Hansjakob Furrer, Bernard Hirschel, Véronique Schiffer, Barbara Hasse, Lorenzo Magenta and Reto Nüesch and has published in prestigious journals such as Clinical Infectious Diseases, AIDS and Infection.

In The Last Decade

Thomas Wagels

9 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Wagels Switzerland 9 290 180 144 106 93 9 417
Nancy Hutcheon United States 8 220 0.8× 210 1.2× 129 0.9× 57 0.5× 20 0.2× 11 431
Caroline Roussillon France 7 149 0.5× 65 0.4× 177 1.2× 98 0.9× 17 0.2× 12 381
Susan Louw South Africa 8 79 0.3× 55 0.3× 48 0.3× 118 1.1× 13 0.1× 38 273
Christine Burty France 3 191 0.7× 94 0.5× 233 1.6× 175 1.7× 8 0.1× 4 473
Louis Evans United Kingdom 7 159 0.5× 226 1.3× 75 0.5× 36 0.3× 21 0.2× 18 339
Aurore Georget France 5 98 0.3× 38 0.2× 110 0.8× 83 0.8× 19 0.2× 6 291
Renee Weinman United States 9 143 0.5× 37 0.2× 292 2.0× 188 1.8× 137 1.5× 13 401
F. Raffi France 6 316 1.1× 139 0.8× 161 1.1× 304 2.9× 11 0.1× 16 530
Isabel Galán Spain 11 79 0.3× 98 0.5× 56 0.4× 22 0.2× 21 0.2× 33 303
S. R. Cole United States 7 178 0.6× 127 0.7× 99 0.7× 58 0.5× 5 0.1× 8 388

Countries citing papers authored by Thomas Wagels

Since Specialization
Citations

This map shows the geographic impact of Thomas Wagels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wagels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wagels more than expected).

Fields of papers citing papers by Thomas Wagels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Wagels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wagels. The network helps show where Thomas Wagels may publish in the future.

Co-authorship network of co-authors of Thomas Wagels

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Wagels. A scholar is included among the top collaborators of Thomas Wagels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Wagels. Thomas Wagels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Fehr, Jan, Dunja Nicca, Parham Sendi, et al.. (2005). Starting or Changing Therapy – A Prospective Study Exploring Antiretroviral Decision–Making. Infection. 33(4). 249–256. 19 indexed citations
2.
Calmy, Alexandra, Barbara Hasse, Véronique Schiffer, et al.. (2004). Pulmonary Arterial Hypertension Related to HIV Infection: Improved Hemodynamics and Survival Associated with Antiretroviral Therapy. Clinical Infectious Diseases. 38(8). 1178–1185. 131 indexed citations
3.
Kahlert, Christian R., et al.. (2004). Ritonavir boosted indinavir treatment as a simplified maintenance ‘mono'-therapy for HIV infection. AIDS. 18(6). 955–957. 30 indexed citations
4.
Opravil, Milos, Enos Bernasconi, Matthias Cavassini, et al.. (2004). Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia. AIDS. 18(15). 2047–2053. 10 indexed citations
5.
Flepp, Markus, Enos Bernasconi, Véronique Schiffer, et al.. (2003). Low Incidence of Community‐Acquired Pneumonia among Human Immunodeficiency Virus–Infected Patients after Interruption ofPneumocystis cariniiPneumonia Prophylaxis. Clinical Infectious Diseases. 36(7). 917–921. 10 indexed citations
6.
Staehelin, Cornelia, Martin Rickenbach, Nicola Low, et al.. (2003). Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study. AIDS. 17(15). 2237–2244. 64 indexed citations
7.
Hirschel, Bernard, Markus Flepp, Heiner C. Bucher, et al.. (2002). Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case–control study from the Swiss HIV Cohort. AIDS. 16(3). 381–385. 21 indexed citations
8.
Opravil, Milos, Bruno Ledergerber, Hansjakob Furrer, et al.. (2002). Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 × 106/l. AIDS. 16(10). 1371–1381. 92 indexed citations
9.
Taffé, Patrick, Martin Rickenbach, Bernard Hirschel, et al.. (2002). Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study. AIDS. 16(5). 747–755. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026